News

ETF Daily News14d
Cantor Fitzgerald Reduces Earnings Estimates for GoDaddy
Cantor Fitzgerald analyst D. Mathivanan now anticipates that the technology company will post earnings per share of $6.64 for the year, down from their previous forecast of $6.74.
Hosted on MSN15d
Cantor Fitzgerald Initiates Coverage of Pharvaris N.V. (PHVS) with Overweight Recommendation
Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of Pharvaris N.V. (NasdaqGS:PHVS) with a Overweight recommendation. Analyst Price Forecast Suggests 102.48% Upside As of ...
Hosted on MSN15d
Cantor Fitzgerald Initiates Coverage of InflaRx N.V. (IFRX) with Overweight Recommendation
Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of InflaRx N.V. (NasdaqGS:IFRX) with a Overweight recommendation. Analyst Price Forecast Suggests 536.20% Upside As of ...
Hosted on MSN15d
Cantor Fitzgerald Initiates Coverage of BioCryst Pharmaceuticals (BCRX) with Overweight Recommendation
Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of BioCryst Pharmaceuticals (NasdaqGS:BCRX) with a Overweight recommendation. Analyst Price Forecast Suggests 86.43% ...
Hosted on MSN15d
Cantor Fitzgerald Initiates Coverage of Astria Therapeutics (ATXS) with Overweight Recommendation
Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of Astria Therapeutics (NasdaqGM:ATXS) with a Overweight recommendation. Analyst Price Forecast Suggests 428.96% Upside ...
Nasdaq15d
Cantor Fitzgerald Initiates Coverage of BioCryst Pharmaceuticals (BMV:BCRX) with Overweight Recommendation
Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of BioCryst Pharmaceuticals (BMV:BCRX) with a Overweight recommendation. Avoro Capital Advisors holds 11,865K shares ...